Question 15

Amiodarone and amantadine are considered a risk according to the ISMP List of Confused Drug Names.

The Institute for Safe Medication Practices identifies amiodarone and amantadine as a pair of medications that can easily be confused due to their similar names, posing a risk to patient safety.

A) Amiodarone and amantadine

This option is correct as both drugs have similar-sounding names, which can lead to prescribing and dispensing errors. Amiodarone is an antiarrhythmic medication used to treat irregular heartbeats, while amantadine is an antiviral and antiparkinsonian drug. Their phonetic similarity increases the likelihood of confusion, making them a notable risk according to the ISMP.

B) Atorvastatin and simvastatin

Although atorvastatin and simvastatin are both statins used to lower cholesterol, they are not included in the ISMP list of confused drug names. The distinction in their names is more apparent, which helps to mitigate the risk of confusion in clinical settings.

C) Furosemide and famotidine

Furosemide and famotidine serve different therapeutic purposes, with furosemide being a diuretic and famotidine an H2 antagonist. Their names do not sound similar enough to warrant concern as a confused drug pair according to the ISMP guidelines.

D) Cephalexin and ciprofloxacin

Cephalexin and ciprofloxacin are both antibiotics but belong to different classes. The difference in their prefixes and suffixes reduces the likelihood of confusion, thus they are not recognized as a risk pair by the ISMP.

Conclusion

Amiodarone and amantadine are identified as a risk pair due to their similar names, which can lead to medication errors. In contrast, the other options, while they may share some characteristics, do not present the same level of confusion according to the ISMP, demonstrating the importance of name differentiation in medication safety.